Possible role of edotecarin, a novel topoisomerase I inhibitor, in therapy-related myelodysplastic syndrome.
Overview
publication date
- January 1, 2007
published in
- Leukemia & lymphoma Journal
Research
keywords
- Antineoplastic Agents
- Carbazoles
- Indoles
- Myelodysplastic Syndromes
- Topoisomerase I Inhibitors
Identity
Scopus Document Identifier
- 34247255977
Digital Object Identifier (DOI)
- 10.1080/10428190600968350
PubMed ID
- 17325867
Additional Document Info
has global citation frequency
volume
- 48
issue
- 1